Provexis plc (AIM:PXS)
London · Delayed Price · Currency is GBP · Price in GBX 0.6175
-0.0450 (-6.79%)
Sep 30, 2025, 5:15 PM GMT+1
Provexis Market Cap
Provexis has a market cap or net worth of 14.47 million as of October 6, 2025. Its market cap has increased by 1.20% in one year.
Market Cap
14.47M
Enterprise Value
13.46M
Revenue
1.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.62
Market Cap Chart
Since September 7, 2005, Provexis's market cap has increased from 2.24M to 14.47M, an increase of 545.52%. That is a compound annual growth rate of 9.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 14.47M | -8.59% |
| Dec 31, 2024 | 15.83M | 9.84% |
| Dec 29, 2023 | 14.42M | -10.34% |
| Dec 30, 2022 | 16.08M | -6.76% |
| Dec 31, 2021 | 17.24M | -2.21% |
| Dec 31, 2020 | 17.63M | 30.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.16B |
| GSK plc | 65.05B |
| Haleon | 29.53B |
| Smith & Nephew | 11.51B |
| ConvaTec Group | 4.79B |
| Hikma Pharmaceuticals | 4.09B |
| HUTCHMED (China) | 2.08B |
| Genus | 1.67B |